Title : Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance.

Pub. Date : 2020

PMID : 32999756






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Expression differences of miR-142-5p between treatment-naive chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance. Imatinib Mesylate MCL1 apoptosis regulator, BCL2 family member Homo sapiens